Clinical trials
Active, not recruiting Dermatitis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Aclaris Therapeutics, Inc. | 1 |
| Kari Nadeau, MD, PhD | 1 |
| Massachusetts General Hospital | 1 |
| Q32 Bio Inc. | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Wei-Che Ko | 1 |
| Zura Bio Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis | 9 |
| Hidradenitis | 3 |
| Hidradenitis Suppurativa | 3 |
| Dermatitis, Atopic | 2 |
| Eczema | 2 |
| Acne Vulgaris | 1 |
| Alopecia | 1 |
| Alopecia Areata | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Cicatrix | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.